Optimising the management of cardiovascular comorbidities in NAFLD patients: it's time to (re-) act!

Gut. 2022 Nov;71(11):2365-2366. doi: 10.1136/gutjnl-2021-326662. Epub 2022 Jan 6.

Authors

Philipp Kasper¹, Sonja Lang¹, Muenevver Demir², Hans-Michael Steffen³

Affiliations

¹ Clinic for Gastroenterology and Hepatology, University Hospital Cologne, Köln, Nordrhein-Westfalen, Germany.
² Department of Hepatology and Gastroenterology, Charité University Medicine, Campus Virchow Clinic and Campus Charité Mitte, Charite Universitatsmedizin Berlin, Berlin, Germany.
³ Clinic for Gastroenterology and Hepatology, University Hospital Cologne, Köln, Nordrhein-Westfalen, Germany [email protected].

PMID: 34992133
DOI: 10.1136/gutjnl-2021-326662

No abstract available

Keywords: cardiovascular complications; cardiovascular disease; chronic liver disease; diabetes mellitus; fatty liver.

Publication types

Letter
Comment

MeSH terms

Cardiovascular Diseases* / epidemiology
Cardiovascular Diseases* / therapy
Diabetes Mellitus, Type 2*
Humans
Insulin Resistance*
Non-alcoholic Fatty Liver Disease* / complications
Non-alcoholic Fatty Liver Disease* / epidemiology
Non-alcoholic Fatty Liver Disease* / therapy
Risk Factors